Follow
Omics
Omics: The English-language neologism omics informally refers to a field of study in biology ending in -omics, such as genomics, proteomics or metabolomics. The related suffix -ome is used to address the objects of study of such fields, such as the genome, proteome or metabolome respectively.
-
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...JAN 15, 2026 | 8:00 AM
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...NOV 12, 2025 | 7:00 AM
In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our understanding of pancreatic ductal adenocarcinoma (PDAC), one of th...OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...SEP 17, 2025 | 8:00 AM
Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights....JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...JUN 10, 2025 | 6:00 AM
Personalized health profiling using multi-omics data has the potential to reveal immunometabolic disruptions among individuals living with HIV (PWH) who are effectively undergoing antiretrov...MAY 28, 2025 | 8:00 AM
Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, me...APR 29, 2025 | 8:00 AM
Only one in four transplant waitlisted patients receive a life-saving organ. Xenotransplantation of pig organs into humans is a promising avenue for addressing organ shortage. Understanding...MAR 26, 2025 | 8:00 AM
Single-cell analysis is a new and rapidly growing field that is shedding new insight into the cellular mechanisms behind the pathogenesis and treatment of infectious diseases and cancer. Cel...FEB 19, 2025 | 10:00 AM
Only 1 in 4 people on US transplant waitlists will received an organ. Transplanting pig xenografts into human decedents affords a unique opportunity to deeply profile and analyze longitudina...FEB 13, 2025 | 7:00 AM
Using next-generation proteomics technologies, organoid-based research models have the potential to revolutionize drug discovery and personalized medicine, improving our understanding of neu...FEB 05, 2025 | 8:00 AM
The advent of the spatial omics era has enabled researchers to acquire vast amounts of transcriptomics and proteomics data. The abundance of a transcript, however, does not necessarily displ...Speaker: Kendra Ritchie , Joseph Melko, MS , Sara Bodbin, PhDNOV 14, 2024 | 10:00 AM
Projects like the Human Immune Health Atlas are an example of the multi-team, high parameter, “big” science that the Allen Institute is known for. The challenge begins when it is...NOV 13, 2024 | 11:00 AM
The STELLARIS confocal platform offers significant advancements for high-multiplex strategies, integrating a tunable white light laser (WLL) with an excitation range from 440 nm to 790 nm an...OCT 22, 2024 | 6:00 AM
The oral cavity acts as the gateway to the respiratory and digestive tract, and is in continuity with the skin, sharing several of its features and structure. The oral cavity consists of var...SEP 26, 2024 | 10:00 AM
Advances in spatial biology enable scientists to visualize multiplexed biomolecules across multiple 'omics technologies at single-cell resolution. However, all of these technologies requ...SEPT 23, 2024 3:00 PM CET
CML is traditionally regarded as a paradigm of precision medicine, under several points of view: 1) it is the first human malignancy whose molecular pathogenesis was unravelled, well before...Speaker: Prof. Simona Soverini
AUG 14, 2024 | 3:00 PM
The Molecular Twin is a proof-of-principle platform that combines data from several clinical and molecular analytes from both tumor and host and applies AI and machine learning approaches to...
Speaker:
Dr. Arsen Osipov
JUN 11, 2024 | 8:00 AM
Cancer genome alterations that cause cancer cells to grow also confer vulnerabilities, which normal cells lack. The challenge is that, for the majority of cancers, we do not understand the r...
On Demand
C.E. CREDITS
Genomics, epigenomics and transcriptomics are often thought of as independent fields, but in our clinical practice we use them combined to increase diagnostic yield both for constitutional a...
Speaker:
Peter Lajos Nagy, MD, PhD
APR 03, 2024 | 9:00 AM
C.E. CREDITS
Cultured mammalian cells, particularly Chinese hamster ovary (CHO) cells are widely used in the biotechnology industry for production of a wide range of therapeutics, predominantly monoclona...
On Demand
C.E. CREDITS
Efficient utilisation of abundant renewable sugars and aromatic chemicals by natural or recombinant microorganisms is a key prerequisite for the economic viability of biotechnological valori...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
JAN 15, 2026 | 8:00 AM
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...
NOV 12, 2025 | 7:00 AM
In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our understanding of pancreatic ductal adenocarcinoma (PDAC), one of th...
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
SEP 17, 2025 | 8:00 AM
Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights....
JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...
JUN 10, 2025 | 6:00 AM
Personalized health profiling using multi-omics data has the potential to reveal immunometabolic disruptions among individuals living with HIV (PWH) who are effectively undergoing antiretrov...
MAY 28, 2025 | 8:00 AM
Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, me...
APR 29, 2025 | 8:00 AM
Only one in four transplant waitlisted patients receive a life-saving organ. Xenotransplantation of pig organs into humans is a promising avenue for addressing organ shortage. Understanding...
MAR 26, 2025 | 8:00 AM
Single-cell analysis is a new and rapidly growing field that is shedding new insight into the cellular mechanisms behind the pathogenesis and treatment of infectious diseases and cancer. Cel...
FEB 19, 2025 | 10:00 AM
Only 1 in 4 people on US transplant waitlists will received an organ. Transplanting pig xenografts into human decedents affords a unique opportunity to deeply profile and analyze longitudina...
FEB 13, 2025 | 7:00 AM
Using next-generation proteomics technologies, organoid-based research models have the potential to revolutionize drug discovery and personalized medicine, improving our understanding of neu...
FEB 05, 2025 | 8:00 AM
The advent of the spatial omics era has enabled researchers to acquire vast amounts of transcriptomics and proteomics data. The abundance of a transcript, however, does not necessarily displ...
Speaker:
Kendra Ritchie
, Joseph Melko, MS
, Sara Bodbin, PhD
NOV 14, 2024 | 10:00 AM
Projects like the Human Immune Health Atlas are an example of the multi-team, high parameter, “big” science that the Allen Institute is known for. The challenge begins when it is...
NOV 13, 2024 | 11:00 AM
The STELLARIS confocal platform offers significant advancements for high-multiplex strategies, integrating a tunable white light laser (WLL) with an excitation range from 440 nm to 790 nm an...
OCT 22, 2024 | 6:00 AM
The oral cavity acts as the gateway to the respiratory and digestive tract, and is in continuity with the skin, sharing several of its features and structure. The oral cavity consists of var...
SEP 26, 2024 | 10:00 AM
Advances in spatial biology enable scientists to visualize multiplexed biomolecules across multiple 'omics technologies at single-cell resolution. However, all of these technologies requ...
SEPT 23, 2024 3:00 PM CET
CML is traditionally regarded as a paradigm of precision medicine, under several points of view: 1) it is the first human malignancy whose molecular pathogenesis was unravelled, well before...
Speaker:
Prof. Simona Soverini
AUG 14, 2024 | 3:00 PM
The Molecular Twin is a proof-of-principle platform that combines data from several clinical and molecular analytes from both tumor and host and applies AI and machine learning approaches to...
Speaker:
Dr. Arsen Osipov
JUN 11, 2024 | 8:00 AM
Cancer genome alterations that cause cancer cells to grow also confer vulnerabilities, which normal cells lack. The challenge is that, for the majority of cancers, we do not understand the r...
On Demand
C.E. CREDITS
Genomics, epigenomics and transcriptomics are often thought of as independent fields, but in our clinical practice we use them combined to increase diagnostic yield both for constitutional a...
Speaker:
Peter Lajos Nagy, MD, PhD
APR 03, 2024 | 9:00 AM
C.E. CREDITS
Cultured mammalian cells, particularly Chinese hamster ovary (CHO) cells are widely used in the biotechnology industry for production of a wide range of therapeutics, predominantly monoclona...
On Demand
C.E. CREDITS
Efficient utilisation of abundant renewable sugars and aromatic chemicals by natural or recombinant microorganisms is a key prerequisite for the economic viability of biotechnological valori...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific